These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 714592)

  • 1. Hypertension associated with the Guillain-Barré syndrome.
    Stapleton FB; Skoglund RR; Daggett RB
    Pediatrics; 1978 Oct; 62(4):588-90. PubMed ID: 714592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised plasma renin activity in the hypertension of the Guillain-Barré syndrome.
    Laufer J; Passwell J; Keren G; Brandt N; Cohen BE
    Br Med J (Clin Res Ed); 1981 Apr; 282(6272):1272-3. PubMed ID: 6784811
    [No Abstract]   [Full Text] [Related]  

  • 3. [Arterial hypertension secondary to Guillain-Barré syndrome. Treatment with a labetalol and chlorpromazine combination. Apropos of a case].
    Ayuso Gatell A; Martínez Ferrer JR; Trenchs Verdaguer X; Pujol Colomer J
    Med Clin (Barc); 1988 Jun; 91(3):105-7. PubMed ID: 3172908
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of Guillain-Barré syndrome accompanied by sympathetic overactivity and hypertensive encephalopathy.
    Okada T; Hiyoshi K; Noto N; Fujita Y; Fuchigami T; Okubo O; Harada K
    Acta Paediatr; 1996 Aug; 85(8):1006-8. PubMed ID: 8863889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism responsible for hypertension in a patient with Guillain-Barré syndrome.
    Minami N; Imai Y; Miura Y; Abe K
    Clin Exp Hypertens; 1995 May; 17(4):607-17. PubMed ID: 7795576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyuria during Guillain-Barré syndrome.
    Hantson P; De Coninck B; Horn JL; Ketelslegers JM; Mahieu P
    Acta Neurol Belg; 1992; 92(2):77-82. PubMed ID: 1534958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine-induced hypertension in Guillain Barré syndrome.
    Ventura HO; Messerli FH; Barron RE
    J Hypertens; 1986 Jun; 4(3):265-7. PubMed ID: 3734443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relations between autonomic dysfunction and skin sympathetic nerve activity in Guillain-Barré syndrome: a microneurographical assessment].
    Yamamoto K; Sobue G; Iwase S; Mano T; Mitsuma T
    Rinsho Shinkeigaku; 1995 Oct; 35(10):1098-103. PubMed ID: 8821492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of parasympathetic functions in Guillain-Barré syndrome].
    Yamamoto T; Tamura N; Nakazato Y; Itokawa K; Maeda A; Abe T; Shimazu K
    Rinsho Shinkeigaku; 2002 Feb; 42(2):126-30. PubMed ID: 12424961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenic hypertension in the Guillain-Barré syndrome.
    Yao H; Fukiyama K; Takada Y; Fujishima M; Omae T
    Jpn Heart J; 1985 Jul; 26(4):593-6. PubMed ID: 3903251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypertension and raised haematocrit: unusual presentation of Guillain-Barré syndrome.
    Richards AM; Nicholls MG; Beard ME; Parkin PJ; Espiner EA
    Postgrad Med J; 1985 Jan; 61(711):53-5. PubMed ID: 3991407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term variability of blood pressure and heart rate in Guillain-Barré syndrome without respiratory failure.
    Annane D; Baudrie V; Blanc AS; Laude D; Raphaël JC; Elghozi JL
    Clin Sci (Lond); 1999 Jun; 96(6):613-21. PubMed ID: 10334967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New data on hormone-dependent hypertension and their significance for the practice].
    Horký K; Petrásek J; Marek J
    Cas Lek Cesk; 1973 Jan; 112(1):3-11. PubMed ID: 4345613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of plasma renin activity and urinary excretion of aldosterone in patients with essential hypertension treated with D-L propranolol].
    Bompiani GD; Scaduto P; Galluzzo A; Morici ML; Mangano MT; Donatelli M
    Minerva Cardioangiol; 1976; 24(7-8):498-505. PubMed ID: 1018743
    [No Abstract]   [Full Text] [Related]  

  • 15. Dysautonomia in Guillain Barre syndrome.
    Bansal BC; Sood AK; Jain SK
    J Assoc Physicians India; 1987 Jun; 35(6):417-9. PubMed ID: 3654548
    [No Abstract]   [Full Text] [Related]  

  • 16. Autonomic involvement in Guillain-Barré syndrome: a review.
    Zochodne DW
    Muscle Nerve; 1994 Oct; 17(10):1145-55. PubMed ID: 7935521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol, renin and hypertension: a review.
    Laragh JH; Bühler FR
    Postgrad Med J; 1976; 52 Suppl 4(604):109-15. PubMed ID: 787950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dysautonomia in Guillaine-Barre syndrome: a clinical analysis of 62 cases].
    Cheng BH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Dec; 24(6):332-5, 382. PubMed ID: 1800057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré Syndrome: incidence, management and outcome of major complications.
    Moore P; James O
    Crit Care Med; 1981 Jul; 9(7):549-55. PubMed ID: 7238063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.